Skip to main content
. 2021 Oct 30;41(2):191–203. doi: 10.1038/s41388-021-02077-w

Fig. 7. Combination of PLK1i and MEKi synergically suppresses CRC tumor growth.

Fig. 7

A BALB/c Nude mice were subcutaneously inoculated with 3 × 106 HCT116 cells on day 0. Tumor-bearing mice (n = 5) were treated with vehicle, AZD6244, BI-2536, or the combination when the tumor volume achieved ≈100 mm3. B Tumor growth curves for mice treated with vehicle, AZD6244, BI-2536, or the combination. C Tumor volume of xenograft tumors on day 26. Data represented as mean ± SD (n = 10). D Representative image of mice and tumors with different treatments on day 26. (E) Weights of xenograft tumors on day 26. Data represented as mean ± SD (n = 10). FH Representative immunohistochemical images of Ki67 and Tunel staining in tumors from each group. Scale bar, 400 μM. G Quantification of Ki67+ cells. Data represented as mean ± SD (n = 5). H Quantification of Tunel+ cells. Data represented as mean ± SD (n = 5). *p < 0.05, **p < 0.01, ***p < 0.001, or ****p < 0.0001.